Cardiovascular

Limb and Life-Saving Treatments

Committed to Helping You Get Your Life Back

If you or a loved one have been diagnosed with peripheral artery disease (PAD) or the more serious form of PAD, critical limb ischemia (CLI), you want solutions. You are not alone. PAD affects approximately 200 million people around the world. You are not the only one facing potential amputation or worse.

Studies show that many PAD-related amputations could have been prevented. We are on a mission to change that. Do not give up if you have already been told amputation is the only option.

The DABRA Endovascular Catheter and Excimer Laser has helped countless patients. Our system delivers safer and faster limb- and life-saving treatment of complex and diffuse arterial blockages in lower vessels. If you have PAD or CLI, there is hope. We help patients transform simple hope to real results. If you want to get back on your feet, potentially preventing amputation, then DABRA may be able to help you. In fact, a pivotal DABRA study demonstrated 94% success—with no adverse events—delivering effective and safe destruction of arterial blockages in patients’ legs.

You get to take advantage of our innovative, advanced laser technology, backed by 16 years of global operation. It is the combination of innovation, tradition, and genuine compassion that you can count on.

Help Spread the Word

DABRA has been delivering safe and successful treatment of arterial blockages in the lower vessels for years. But your podiatrist, cardiologist, interventionalist, or physician might not know about our system. Tell your doctor about DABRA. It might make the difference between amputation and limb preservation.

Peripheral Artery DiseaseDABRA FAQPatient EducationReimbursementFind A Doctor

Peripheral Artery Disease

Peripheral artery disease (PAD) is a narrowing of the peripheral arteries, which reduces blood flow to the arms, hands, legs, and feet. PAD is most common in leg arteries. If left untreated, PAD can lead to non-healing wounds, gangrene, amputation, and even death. Even in the absence of more severe symptoms, PAD can cause chronic pain as well as limit mobility and activity, adversely affecting quality of life.

With over 200 million people suffering from PAD, we still have a lot of work to do. Patient success stories like the following provide us with all the motivation we could ever need to continue blazing a trail forward to help as many patients as possible. Watch how this DABRA patient transitioned from hobbling on a cane to winning a tennis competition within the same month.

 

Targeted Smart Laser for Peripheral Artery Disease

PAD is a disease in which plaque builds up in the arteries that carry blood to your head, organs, and limbs. Plaque is made up of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood.

When plaque builds up in the body’s arteries, the condition is called atherosclerosis. Over time, plaque can harden and narrow the arteries. This limits the flow of oxygen-rich blood to your organs and other parts of your body.

There are no limitations on the types of arterial plaque our DABRA Excimer Laser can safely cut, including thrombus, atheroma, fibroatheroma, and calcium.

 

Healing with the Power of Light

Using laser energy to treat vascular obstructions dates back almost 30 years. We are building on that history with continuous research and development to bring the very best laser-technology innovations to our patients.

DABRA treats PAD and critical limb ischemia (CLI) with photons, particles of light. Our laser produces 308 narrow-band ultraviolet B (308-nm UVB) photons. 308-nm UVB has been shown to be the most effective wavelength for treating complex PAD and CLI cases. It is this use of ultraviolet light that makes DABRA an excimer laser.

DABRA photochemically ablates arterial blockages, reducing all types of arterial plaque into their fundamental chemistry, which minimizes downstream debris. Lasing plaque and reducing it down small enough allows any leftover particles to harmlessly wash downstream without obstructing arteries.
 

Fast Treatment of Peripheral Artery Disease

DABRA patients can look forward to minimal and even no discomfort or pain. Multiple treatments may be required depending on your case, but treatment times have been as low as just 15 minutes, as demonstrated in the following video.

 

There Is Always Hope

Dealing with PAD or CLI can be scary. But you have treatment options. Never give up hope. Watch how our DABRA Endovascular Catheter and Excimer Laser saved a patient’s petrified foot in just 12 minutes.

DABRA FAQ

How does the DABRA Endovascular Catheter and Excimer Laser work?
The DABRA Endovascular Catheter and Excimer Laser work in concert.

The DABRA Endovascular Catheter is a single-use catheter that tracks the true lumen, the normal passageway of blood, without a guidewire. Because it is wireless, the catheter tends not to go subintimal, which helps minimize trauma to the vasculature and helps prevent unplanned blood leakage. Wireless endovascular catheters have been shown to be safer for patients.

DABRA is a full catheter tip forward cutter, delivering fast and complete ablation of all types of arterial plaque, including thrombus, atheroma, fibroatheroma, and calcium.

The DABRA laser is the excimer laser power source for the DABRA Endovascular Catheter. The DABRA laser produces 308-nm UVB photons, which photochemically ablate arterial blockages, reducing calcium, thrombus, and atheroma into their fundamental chemistry, minimizing downstream debris. Any particles that might be created are small enough that the bloodstream typically absorbs and safely carries them away.

Does the DABRA procedure hurt?
You may feel a mild sensation or slight discomfort from the catheter.

The excimer laser is on the cool end of the UV light spectrum, which means it does not generate sufficient heat to damage the arterial wall or cause notable discomfort.

Is DABRA treatment safe?
Yes. A pivotal DABRA study demonstrated 94% success—with no adverse events—delivering effective and safe destruction of arterial blockages in patients’ legs.

Does DABRA have FDA clearance?
Yes. The FDA granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease (PAD) treatment.

You can view the original FDA update posted on FDANEWS.

Is DABRA treatment invasive?
No. DABRA treatment is a minimally invasive endovascular technique. As a minimally invasive technology, the DABRA excimer laser has an obvious benefit over traditional, intrusive surgical methods. Additional advantages of DABRA include precision and safety.

Who is a candidate for DABRA treatment?
Good candidates have severe narrowing of peripheral arteries that cannot be easily treated with angioplasty and stenting and are not ideal candidates for bypass surgery. Additionally, doctors recommend laser treatment for patients suffering from certain chronic illnesses who are considered poor surgical candidates.

How long is recovery time following DABRA treatment?
Recovery times can vary across patients and cases. Some DABRA patients have been able to walk out of the hospital the same day as their procedure. We even had a DABRA patient win a tennis competition within the same month as their treatment.

How do I prepare for DABRA treatment?
Preparation varies across patients and cases. Always consult your physician or podiatrist as well as the cardiologist, interventionist, or endovascular specialist who will be treating you. You should also make sure you are given clear post-treatment instructions for the best chance of successful recovery.

Patient Education

Reimbursement

We are out to change the world for the better. When we see patients not getting the best care possible due to lack of affordable healthcare and treatment accessibility, we do something about it. We have designed the DABRA Endovascular Catheter and Excimer Laser to be more affordable for your physicians. It is your right to demand the best healthcare from your doctor. It is your right to have the best chance of preventing amputation and living the life you deserve.

DABRA Endovascular Catheter and Excimer Laser treatments are becoming the standard of care for peripheral artery disease (PAD) and critical limb ischemia (CLI).

For more than a decade, carriers including Medicare, Medicaid, Blue Cross, Blue Shield, Aetna, Cigna, UnitedHealthcare, and many others have reimbursed excimer laser treatments under special laser CPT® codes 96920, 96921, and 96922.

Coverage may vary according to your individual plan.

Talk to your physician’s billing staff for details about your insurance coverage.

Find a Doctor Near You

Submit and Find a Doctor

  • "DABRA Pulled MAGIC In 1 Minute"

    "We had a dramatic DABRA case. Facing amputation. We were struggling for two hours without any success for a CTO right AT. DABRA pulled MAGIC in 1 minute. We crossed the lesion. It’s a two-in-one. You are crossing the CTO and modifying the plaque. Aborted amputation."

     

    Athar Ansari, MD, FACC - California Heart & Vascular Clinic El Centro, CA

     

  • "We Were Able To Stay Within True Lumen"

    "When it comes to total occlusion, normally if you can’t cross with a guidewire, you can’t do it. With DABRA, we were able to stay within the true lumen and recanalize without a wire in front."

     

    Ehtisham Mahmud, MD, FACC, FSCAI - UC San Diego Cardiovascular Clinic

     

  • "A Part Of Everyone’s Armamentarium"

    "I think DABRA should be a part of everyone’s armamentarium."

     

    Athar Ansari, MD, FACC - California Heart & Vascular Clinic El Centro, CA

     

  • "In my experience, none of the other devices maintain the vessel…"

    "It is remarkable technology. I think it’s going to be a real game changer. In my experience none of the other devices maintain the vessel open like DABRA without a stent. Plus, you don’t have to spend so much time in the Cath Lab with exposure to radiation."

     

    Ernesto Rodriguera, MD, FACC - Excel Medical Center Tijuana, Mexico

     

  • "I Think That’s Spectacular"

    "The key is to recanalize it safely and effectively. With this new catheter, I am able to do it as an outpatient with 3 minutes of fluoro time. I think that’s spectacular."

     

    Athar Ansari, MD, FACC - California Heart & Vascular Clinic El Centro, CA

     

  • "The Cost Savings Are Remarkable"

    "The laser should revolutionize the interventional peripheral world. The cost savings are remarkable. They are about a third of the price."

     

    Ernesto Rodriguera, MD, FACC - Excel Medical Center Tijuana, Mexico

     

  • "Really Simple And Very Safe"

    "It’s very easy, very simple, very trackable, and I did not encounter any problems in the technique. It is really simple and very safe."

     

    Marzia Lugli, MD - Hesperia Hospital Mendona, Italy